Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Heterogeneity of HLA genetic factors in IDDM susceptibility

  • 25 Accesses

  • 6 Citations


The association of certain HLA-D alleles with insulin-dependent diabetes mellitus (IDDM) is well known. One hundred and sixty-one non-related diabetic individuals and 142 non-related healthy controls were typed for the HLA DR-DQw-Dw association, using a restriction fragment length polymorphism (RFLP) typing method that combines three probe/enzyme systems: DRB/Taq I, DQB/Taq I, and DQB/Bam HI. Comparison of frequencies in both diabetics and controls confirms previous results in terms of HLA class II and IDDM association. Moreover, we have found that DR3/4 heterozygous individuals are more susceptible to IDDM when they are also Dw25 (associated with B18) than when they are Dw24 (associated with B8). Using oligonucleotide dot-blot hybridizations we analyzed the HLA-DQB1 sequence of DR3, Dw24 and DR3, Dw25 homozygous individuals, and we found no difference at position 57 between these two DR3-carrying haplotypes. This observation points to the heterogeneity of HLA genetic factors in IDDM susceptibility.

This is a preview of subscription content, log in to check access.


  1. Amar, A., Nepom, G. T., Mickelsen, E., Erlich, H., and Hansen, J. A.: HLA-DP and HLA-DQ genes in presumptive HLA-identical siblings: structural and functional identification of allelic variation. J Immunol 138: 1947–1953, 1987

  2. Aparicio, J. M. R., Wakisaka, A., Takada, A., Matsuura, N., and Aizawa, M.: HLA-DQ system and insulin-dependent diabetes mellitus in Japanese: does it contribute to the development of IDDM as it does in Caucasian? Immunogenetics 28: 240–246, 1988

  3. Betuel, H., Gebuhrer, L., Font, M. P., and Freidel, A. C.: Division of HLA-DQw1 by DNA typing and an alloantiserum: DR1, subtypes of DR2 and DRw6; DRw10 and rare haplotypes DRw8-DQw1, DRw11-DQw1 fit in two clusters. In B. Dupont (ed.): Immunobiology of HLA, Vol II, Histocompatibility Testing 1987, pp. 279–280, Springer, New York, 1989

  4. Bidwell, J.: DNA-RFLP analysis and genotyping of HLA-DR and DQ antigens. Immunol Today 9 (1): 18–23, 1988

  5. Bidwell, J. L., Bidwell, E., Savage, D. A., Middleton, D., Klouda, P. T., and Bradley, B. A.: A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10. Transplantation 45: 640–646, 1988

  6. Bignon, J. D., Semana, G., Tiercy, J. L., Simons, M., Lalouel, J. M., and Cohen, D.: DNA-RFLP analysis: HLA-DR beta workshop report. In B. Dupont (ed.): Immunobiology of HLA, Vol I, Histocompatibility Testing 1987, pp. 851–860, Springer, New York, 1989

  7. Bodmer, W. F., Albert, E., Bodmer, J. G., Dupont, B., Mach, B., Mayr, W. R., Sasuzuki, T., Schreuder, G. M. Th., Svejgaard, A., and Terasaki, P. I.: Nomenclature for factors of the HLA system, 1987. In B. Dupont (ed.): Immunobiology of HLA, Vol I, Histocompatibility Testing 1987, pp. 72–79, Springer, New York, 1989

  8. Cohen, D., Paul, P., Le Gall, I., Marcadet, A., Font, M. P., Cohen-Haguenauer, O., Sayagh, B., Cann, H., Lalouel, J. M., and Dausset, J.: DNA polymorphism of class I and II regions. Immunol Rev 85: 87–105, 1985

  9. Cohen-Haguenauer, O., Robbins, E., Massart, C., Busson, M., Deschamps, I., Hors, J., Lalouel, J., Dausset, J., and Cohen, D.: A systematic study of HLA class II-β DNA restriction diabetes mellitus. Proc Natl Acad Sci USA 82: 3335–3339, 1985

  10. Cox, N. J., Mela, P. A., Zmijewski, C. M., and Spielman, R.: HLA-DR typing “at the DNA level”: RFLPs and subtypes detected with a DRβ cDNA probe. Am Hum Genet 43: 954–963, 1988

  11. Dawkins, R. L., Christiansen, F. T., Kay, P. H., Garlepp, M., McCluskey, P. N., Hollingsworth, P. N., and Zilko, P. J.: Disease associations with complotypes, supratypes and haplotypes. Immunol Rev 70: 5–22, 1983

  12. Deschamps, I., Marcelli-Barge, A., Lallemand, N., Poirier, J. C., Bochu, V., Prévost, P., Busson, A., Massét, M., Lestradet, H., and Hors, J.: Study of cis and trans interactions between extended HLA-haplotypes in insulin-dependent diabetes. Tissue Antigens 31: 259–269, 1988

  13. Fauchet, R., Van Leeuwen, A., Yunis, E. J., and Schreuder, G. M. T.: HLA DRw10. In E. D. Albert, M. P. Baur, W. R. Mayr (eds.): Histocompatibility Testing 1984, pp. 201–202, Springer, New York, 1984

  14. Festenstein, H., Awad, J., Hitman, G. A., Cutbush, S., Groves, A. V., Cassell, P., Ollier, W., and Sachs, J. A.: New HLA DNA polymorphism associated with autoimmune diseases. Nature 322: 64–67, 1986

  15. Kaufman, J. F., and Strominger, J. L.: HLA-DR light chain has a polymorphic N-terminal region and a conserved immunoglobulin-like C-terminal region. Nature 297: 694–697, 1982

  16. Kaufman, J. F, Auffray, C., Korman, A. J., Schackelford, D. A., and Strominger, J. L.: The class II molecules of the human and murine Major Histocompatibility Complex. Cell 36: 1–13, 1984

  17. Klarescog, L., Sandberg-Trägardh, L., Rask, L., Lindblom, J. B., Curman, B., and Peterson, P. A.: Chemical properties of human Ia antigens. Nature 265: 248–251, 1977

  18. Korman, A. J., Boss, J. M., Spies, T., Sorrentino, R., Okada, K., and Strominger, J. L.: Genetic complexity and expression of human class II histocompatibility antigens. Immunol Rev 85: 45–78, 1985

  19. Laporte, R. E., Tajima, N., and Akerblom, H. K.: Geographic differences in the risk of insulin-dependent diabetes mellitus: the importance of registries. Diabetes Care 8: 101–108, 1985

  20. Larhamar, D., Hyldig-Nielsen, J. J., Servenius, B., Andersson, G., Rask, L., and Peterson, P. A.: Exon-intron organization and complete nucleotide sequence of a human major histocompatibility antigen DCβ gene. Proc Natl Acad Sci USA 80: 7313–7317, 1983

  21. Marcadet, A., O'Connell, P., and Cohen, D.: Standardized Southern blot workshop technique. In B. Dupont (ed.): Immunobiology of HLA, Vol I, Histocompatibility Testing 1987, pp. 587–590, Springer, New York, 1989a

  22. Marcadet, A., Dupont, B., and Cohen, D.: Organization and design of the Southern blot component of the Xth Histocompatibility Workshop. In B. Dupont (ed.): Immunobiology of HLA, Vol I, Histocompatibility Testing 1987, pp. 560–566 Springer New York, 1989b

  23. Martell, M., Marcadet, A., and Cohen, D.: HLA class II typing by the workshop defined RFLP specifities in unrelated individuals. In B. Dupont (ed.): Immunobiology of HLA, Vol I, Histocompatibility Testing 1987, pp. 943–952, Springer, New York, 1989

  24. Nepom, B. S., Schwarz, D., Palmer, J. P., and Nepom, G. T.: Transcomplementation of HLA genes in IDDM, HLA-DQ α- and β-chains produce hybrid molecules in DR3/4 heterozygotes. Diabetes 36: 114–117, 1987

  25. Rollini, P., Mach, B., and Gorski, J.: Linkage map of three HLA-DR β-chain genes: evidence for a recent duplication event. Proc Natl Acad Sci USA 82: 7197–7201, 1985

  26. Ronningen, K. S., Markussen, G., Iwe, T., and Thorsby, E.: An increased risk of insulin-dependent diabetes mellitus (IDDM) among HLA-DR4, DQw8/DRw8,DQw4 heterozygotes. Hum Immunol 24: 165–173, 1989

  27. Saiki, R. K., Bugawan, T. L., Horn, G. T., Mullis, K. B., and Erlich, H. A.: Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes. Nature 324: 163–166, 1986

  28. Segall, M.: Specificity analysis of DQA fragments in core cell lines. In B. Dupont (ed.): Immunobiology of HLA, Vol I, Histocompatibility Testing 1987, pp. 886–888, Springer, New York, 1989a

  29. Segall, M.: Specificity analysis of DRA fragments in core cell lines. In B. Dupont (ed.): Immunobiology of HLA, Vol I, Histocompatibility Testing 1987, pp. 885–886, Springer, New York, 1989b

  30. Semana, G., Bignon, J. D., Quillivic, F., Cheneau, M. L., Herniou, E., Muller, J. Y., Genetet, B., and Fauchet, R.: Definition of DRw10 specificity by restriction fragment length polymorphism. Tissue Antigens 32: 113–120, 1988

  31. Sheehy, M. J., Scharf, S. J., Rowe, J. R., Neme de Gimenez, M., Meske, L. M., Erlich, H. A., and Nepom, B. S.: A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and −DQ alleles. J Clin Invest 83: 830–835, 1989

  32. Svejgaard, A., Platz, P., and Ryder, L. P.: HLA and disease 1982 — a survey. Immunol Rev 70: 193–218, 1983

  33. Todd, J. A., Bell, J. I., and McDevitt, H. O.: HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599–604, 1987

  34. Tonnelle, C., DeMars, R., and Long, E. O., DOβ: a new β chain in HLA-D with a distinct regulation of expression. EMBO J 4: 2839–2847, 1985

  35. Tosi, R., Vela, M., Adorno, D., Longo, A., Papola, F., Maccarone, D., Centis, D., Tanigaki, N., Raponi, M. P., Candela, A., Campea, L., Orsini, M., and Ferrara, G. B.: Radioimmunoassay typing gives a more precise definition of the HLA association of type I (insulin-dependent) diabetes. Diabetologia 29: 430–433, 1986

  36. Trowsdale, J., Young, J. A. T., Kelly, A.P., Austin, P. J., Carson, S., Meunier, H., So, A., Elrich, H. A., Spielman, R. S., Bodmer, J., and Bodmer, W. F.: Structure, sequence and polymorphism in the HLA-D region. ImmunolRev 85: 5–43, 1985

  37. Trucco, M., and Ball, E.: RFLP analysis of DQ-beta gene: workshop report. In B. Dupont (ed.): Immunobiology of HLA, Vol I, Histocompatibility Testing 1987, pp. 860–867, Springer, New York, 1989

Download references

Author information

Additional information

Offprint requests to: D. Cohen.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Martell, M., Marcadet, A., Moine, A. et al. Heterogeneity of HLA genetic factors in IDDM susceptibility. Immunogenetics 31, 233–240 (1990).

Download citation


  • Diabetes Mellitus
  • Genetic Factor
  • Fragment Length
  • Length Polymorphism
  • Restriction Fragment Length Polymorphism